News | June 26, 2013

GE Healthcare to Acquire Mammography Assets of Rayence

GE Healthcare to provide a quality solution with affordable costs while broadening mammography portfolio by acquiring Value Digital Mammography

June 26, 2013 — GE Healthcare announced that it has agreed to acquire certain mammography assets of Rayence, a subsidiary of Vatech Co. Ltd., a Korean X-Ray manufacturer. The mammography assets of Rayence will, at closing, become part of the Detection and Guidance Solutions (DGS) business unit of GE Healthcare.

Given the dynamic emerging healthcare market, this acquisition is strategically significant as it will allow GE Healthcare to expand its mammography product range to the Value Mammography segment, estimated to be over $200 million. "This opportunity represents another very important step in the company’s strategy of offering complete solutions that meet the needs of our global customers, while helping to provide more access to quality healthcare at a lower cost," said Hooman Hakami, president & CEO — DGS.

“At GE Healthcare we are very excited about the future of Women’s Healthcare. With the mammography assets of Rayence, tailored for regions with specific cost and access needs, we add capability that allows us to bring affordable mammography solutions to new users and rural communities around the world, in particular physicians undertaking screening programs for breast cancer diagnosis. In addition, when combined with GE's core imaging capabilities, we will create a system that will have best in class image quality at the lowest total cost of ownership,” said Prahlad Singh, general manager — women’s health, GE Healthcare, DGS.

In addition, the acquisition is part of GE Korea’s growth strategy, “In Korea, For the World.” This deal is especially meaningful as GE Healthcare has identified a Korean company with remarkable technologies in mammography and plans to continue local engineering and production while targeting the global market. GE Healthcare will also play a crucial role for Rayence to secure a sales channel in the global market by signing a separate supply agreement of CMOS detector.

Laurent Rotival, president and CEO of GE Healthcare Korea, said, “This acquisition is another example of Korea’s world class R&D capabilities coming together with GE’s global technology leadership. Our ‘In Korea, For the World’ strategy creates win-win partnerships with local talent and companies.”

James Hyun, CEO of Rayence said, “This deal is meaningful in that Rayence has secured a solid global business partner for supplying CMOS detectors. I am very pleased that Rayence’s technology capabilities were acknowledged and products made by Rayence will be distributed to the world by GE Healthcare, thereby contributing to the enhancement of women’s health. Rayence plans to invest the money earned through the sale of our mammography assets into the R&D of core parts for x-ray devices including detectors and expansion of manufacturing lines.”

Rotival added, “GE Healthcare will continue to be a strong partner by investing in Korea and strengthening our joint commitment to our customers and our communities in helping them deliver the best quality and cost effective patient care.”

The transaction is subject to customary closing conditions and is expected to close in the third quarter.

For more information: www.rayence.com

Related Content

Breast Cancer Follow-up Imaging Varies Widely
News | Breast Imaging | July 13, 2018
July 13, 2018 — Follow-up imaging for women...
Invision Diagnostics Installs VolparaEnterprise Software to Enhance Mammography Image Quality
News | Mammography | July 11, 2018
Invision Diagnostics, a provider of mobile mammography services across North and South Carolina, announced that it is...
Breast Cancer Studies Ignore Race, Socioeconomic Factors
News | Women's Health | July 11, 2018
A new commentary appearing in the July issue of Cancer Causes & Control points to evidence that social factors help...
Jeffrey Hoffmeister, M.D.

Jeffrey Hoffmeister, M.D.

Feature | Breast Imaging | July 05, 2018 | By Jeffrey Hoffmeister, M.D.
When women reach age 40, an annual mammogram becomes a necessary part of their healthcare ritual — regardless if they...
Researcher Investigates Eliminating Radiation for HER2-Positive Breast Cancer
News | Radiation Therapy | July 02, 2018
Researchers at The University of Kansas Cancer Center have launched a clinical trial that eliminates radiation from the...
Norwegian Study Confirms Higher Cancer Rate in Women with Dense Breast Tissue
News | Breast Density | July 02, 2018
A large Norwegian study using automated breast density measurements found that women with mammographically dense breast...
3-D Imaging and Computer Modeling Capture Breast Duct Development

An image of a developing mammary duct. Image courtesy of Andrew Ewald.

News | Breast Imaging | June 28, 2018
A team of biologists has joined up with civil engineers to create what is believed to be the first 3-D computer model...
FDA Article Underscores Benefits of Adequate Breast Compression for Mammography Image Quality
News | Mammography | June 26, 2018
Inadequate breast commission played a role in up to 38 percent of mammogram image quality deficiencies, according to a...
Clinical Trial Testing Topical Gel to Reduce Breast Density
News | Breast Density | June 19, 2018
Women with dense breast tissue soon might be adding a new product to their skincare routine to help them fight breast...
California Women In Favor of Extending State's Breast Density Inform Law
News | Breast Density | June 15, 2018
A recent survey of California women found that 95 percent of respondents want the state’s breast density inform law to...
Overlay Init